Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...
Inogen, Inc. INGN has been gaining from its unique direct-to-customer business model. Solid performance in the first quarter of 2021 and a strong product portfolio also buoy optimism. However, ...
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of ...
21d
Inogen Announces the Launch of Aurora CPAP Masks for Obstructive Sleep Apnea in the United States
Engineered for superior comfort, reliability, and usability, Aurora Masks establishes Inogen’s presence in the growing ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of ...
Inogen Inc (NASDAQ:INGN), a medical technology company, reported fourth-quarter 2023 revenues of $75.90 million, missing the consensus of $76.99 million. Fourth quarter total revenue fell from $88.1 ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of ...
Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the ...
Inogen, Inc. INGN is gaining on its solid product portfolio expansion and strong momentum within European markets. However, forex headwinds have been offsetting the positives to some extent. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results